Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
3.460
+0.025 (0.73%)
At close: Jan 8, 2026, 4:00 PM EST
3.371
-0.089 (-2.58%)
After-hours: Jan 8, 2026, 5:25 PM EST
PCSA's stock price has decreased by -86.06% in the past year and price targets may not have had time to catch up.
Processa Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$25.00
Upside
+622.54%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $25 | Strong Buy | Maintains | $50 → $25 | +622.54% | Sep 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $150 → $50 | Strong Buy | Maintains | $150 → $50 | +1,345.09% | Jun 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +4,235.26% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +4,235.26% | Oct 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +4,235.26% | Aug 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $200 → $150 | Strong Buy | Maintains | $200 → $150 | +4,235.26% | Aug 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | +5,680.35% | Aug 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | +5,680.35% | Jun 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $200 | Strong Buy | Reiterates | $200 | +5,680.35% | May 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $200 | Strong Buy | Initiates | $200 | +5,680.35% | Apr 25, 2024 |
| Benchmark | Benchmark | Buy Reiterates $100 | Buy | Reiterates | $100 | +2,790.17% | Mar 6, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 17, 2023 |
| Benchmark | Benchmark | Buy Maintains $4,500 → $2,000 | Buy | Maintains | $4,500 → $2,000 | +57,703.47% | Apr 4, 2023 |
| Oppenheimer | Oppenheimer | Buy Maintains $2,500 → $1,500 | Buy | Maintains | $2,500 → $1,500 | +43,252.60% | Apr 3, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $4,500 → $2,500 | Strong Buy | Maintains | $4,500 → $2,500 | +72,154.34% | Jan 12, 2023 |
| Maxim Group | Maxim Group | Strong Buy Initiates $4,500 | Strong Buy | Initiates | $4,500 | +129,957.80% | Apr 19, 2022 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.